Break through the core market of ASEAN! Nortion's composite steep pulse therapy device officially launches in Vietnam, opening a new chapter in precision urology treatment!
On March 19, 2026, Shanghai Nortion Medical Technology Co., Ltd. (hereinafter referred to as "Nortion Medical") successfully obtained the Vietnam Medical Device Import and Export Registration Certificate for its independently developed composite steep pulse therapy equipment.This is another key milestone of Nortion's globalization strategy after its product layout in Indonesia, Türkiye and Thailand, marking that China's innovative medical technology has further penetrated into the urological diagnosis and treatment system in Southeast Asia, and provided the local patients with internationally leading "China solutions".
Vietnam has a population of nearly 100 million. The accelerated aging and lifestyle changes have promoted the incidence rate of urinary system diseases (such as prostatic hyperplasia and tumor) to continue to rise. However, the local high-end minimally invasive treatment equipment still relies on imports, and traditional surgery has pain points such as large trauma and slow recovery. With the deepening of healthcare system reform in Vietnam, there is an urgent demand for efficient and safe innovative technologies in both public and private hospitals, creating vast opportunities for the export of high-end medical equipment from China. Nortion Medical precisely addresses this demand gap and provides the Vietnamese market with a dual value of "precision treatment+efficiency improvement" through differentiated technology.
The Nortion Medical Compound Steep Pulse Therapy Equipment adopts the world's leading IRE technology and has three core advantages:
·Ultra minimally invasive precise ablation: precise breakdown of the lesion cell membrane through high-voltage short pulses, avoiding thermal damage, protecting blood vessels and nerves, and greatly reducing surgical risks;
·Surgical efficiency revolution: The single treatment time is as short as 15-45 minutes, and patients can get out of bed and move around within 24 hours after surgery, significantly improving hospital bed turnover;
·Widely applicable: covering high-risk urological diseases such as benign prostatic hyperplasia and early prostate cancer, achieving "one machine, two treatments".
This device has obtained China NMPA Class III certification and EU CE certification, and its clinical efficacy has been endorsed by multiple international journals.
The international layout is in full swing: the ASEAN+Eurasia corridor is fully connected
The acquisition of the Vietnamese registration certificate marks the official completion of Nortion Medical's "golden puzzle" in the core market of ASEAN:
·Indonesia (entry in January 2025): Seize the largest medical market in Southeast Asia and establish a regional training center;
·Türkiye (accessed in December 2025): open up the Eurasian hub and radiate the markets in the Middle East and North Africa.
·Thailand (admitted in January 2026): relying on the network of high-end private hospitals, creating a clinical benchmark in the Asia Pacific region;
At this point, Nuosheng has formed a three-dimensional network spanning emerging and mature markets through the "technology going global+localized services" model, providing a replicable Chinese intelligent manufacturing paradigm for urology worldwide.
Future prospects: Deeply cultivating Vietnam, radiating ASEAN medical upgrades
Nortion Medical will simultaneously promote three major actions:
·Top hospitals jointly establish demonstration centers: cooperate with top tier hospitals in Hanoi and Ho Chi Minh City to carry out surgical teaching and clinical research;
·Localized service network: Cooperate with local distributors in Hanoi to establish a spare parts center and provide 24-hour response technical support;
·Collaboration of medical insurance policies: Jointly promote the inclusion of treatment projects in the commercial insurance coverage list with the Vietnamese side, and lower the payment threshold for patients.
Vietnam is the 'key engine' of Nortion's ASEAN strategy. Nortion's Vice President of International Business stated, 'We will drive market trust with clinical effectiveness and make Chinese innovative technology an accelerator for Vietnam's urinary health upgrade.'
From the coast of the East China Sea to the banks of the Mekong River, Nortion Medical is using hardcore technology to open the door to global health. Behind every registration certificate is China's reverence for life and health, as well as its firm commitment to the "Healthy Silk Road". In the future, Nortion will continue to expand into markets such as Malaysia and the Philippines, bringing the "Chinese solution" of precision minimally invasive treatment to the world!
